Association study between the LINGO1 gene and Parkinson's disease in the Italian population

Parkinsonism and Related Disorders

Volumn 17, Issue 8, 2011, Pages 638-641

  Annesi, F ^a   De Marco, E V ^a   Rocca, F E ^a   Nicoletti, A ^b   Pugliese, P ^c   Nicoletti, G ^a,c   Arabia, G ^c   Tarantino, P ^a   De Mari, M ^d   Lamberti, P ^d   Gallerini, S ^e   Marconi, R ^e   Epifanio, A ^f   Morgante, L ^f   Cozzolino, A ^g   Barone, P ^g   Torchia, G ^c   Zappia, M ^b   Annesi, G ^a   Quattrone, A ^c,h  

^a INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e MISERICORDIA HOSPITAL   (Italy)

^f UNIVERSITY OF MESSINA   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h CNR   (Italy)

Author keywords

LINGO1; Parkinson's disease; Polymorphisms

Indexed keywords

ADENINE; CYTOSINE; GENE PRODUCT; GUANOSINE; LEUCINE RICH REPEAT KINASE 2; LINGO 1 PROTEIN; THYMIDINE; UNCLASSIFIED DRUG;

AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE ASSOCIATION; ESSENTIAL TREMOR; ETHNIC GROUP; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; ITALIAN; ITALY; LINGO1 GENE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; COHORT STUDIES; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; ITALY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 80052379807     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.06.020     Document Type: Article

References (12)

1. Shahed J., Jankovic J. Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord 2007, 13(2):67-76.
2. Stefansson H., Steinberg S., Petursson H., Gustafsson O., Gudjonsdottir I.H., Jonsdottir G.A., et al. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet 2009, 41(3):277-279.
3. Mi S., Lee X., Shao Z., Thill G., Ji B., Relton J., et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 2004, 7(3):221-228.
4. Inoue H., Lin L., Lee X., Shao Z., Mendes S., Snodgrass-Belt P., et al. Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models. Proc Natl Acad Sci U S A 2007, 104(36):14430-14435.
5. Nicoletti A., Pugliese P., Nicoletti G., Arabia G., Annesi G., De Mari M., et al. The FRAGAMP study: environmental and genetic factors in Parkinson's disease, methods and clinical features. Neurol Sci 2010, 31(1):47-52.
6. Haubenberger D., Hotzy C., Pirker W., Katzenschlager R., Brücke T., Zimprich F., et al. Role of LINGO1 polymorphisms in Parkinson's disease. Mov Disord 2009, 24(16):2404-2407.
7. Vilariño-Güell C., Ross O.A., Wider C., Jasinska-Myga B., Cobb S.A., Soto-Ortolaza A.I., et al. LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism Relat Disord 2010, 16(2):109-111.
8. Vilariño-Güell C., Wider C., Ross O.A., Jasinska-Myga B., Kachergus J., Cobb S.A., et al. LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics 2010, 11(4):401-408.
9. Pellecchia M.T., Varrone A., Annesi G., Amboni M., Cicarelli G., Sansone V., et al. Parkinsonism and essential tremor in a family with pseudo-dominant inheritance of PARK2: an FP-CIT SPECT study. Mov Disord 2007, 22(4):559-563.
10. Thier S., Lorenz D., Nothnagel M., Stevanin G., Dürr A., Nebel A., et al. LINGO1 polymorphisms are associated with essential tremor in Europeans. Mov Disord 2010, 25(6):709-715.
11. Klebe S., Thier S., Lorenz D., Nothnagel M., Schreiber S., Klein C., et al. LINGO1 is not associated with Parkinson's disease in German patients. Am J Med Genet B Neuropsychiatr Genet 2010, 153B(6):1173-1178.
12. Guo Y., Jankovic J., Song Z., Yang H., Zheng W., Le W., et al. LINGO1 rs9652490 variant in Parkinson disease patients. Neurosci Lett 2010, 487(2):174-176.